Immunogen Inc. buy JPMorgan Chase & Co.
Start price
13.09.23
/
50%
€15.24
Target price
13.09.24
€20.50
Performance (%)
90.15%
End price
14.09.24
-
Summary
This prediction is currently being closed. With a performance of 90.15% the BUY prediction by JPMorgan_Chase___Co_ is a big success. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Immunogen Inc. | - | - | - |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Immunogen Inc. diskutieren
ImmunoGen, Inc. (NASDAQ: IMGN) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $22.00 price target on the stock, up previously from $9.00.
Ratings data for IMGN provided by MarketBeat
In the thread Trading Immunogen Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten